03c-GrowthHormone-2
Regulation of Growth Hormone
Hypothalamus Role
Growth hormone release is regulated by the hypothalamus.
Cells in the hypothalamus produce peptide hormones that are released into a capillary bed and travel through a portal system to the anterior pituitary.
Anterior Pituitary Function
In the anterior pituitary, peptide hormones act on somatotropes to stimulate growth hormone production.
Regulatory Mechanisms
Positive Regulator:
Growth Hormone Releasing Hormone (GHRH) from the arcuate nucleus stimulates adenylyl cyclase activity, increasing cAMP levels and promoting growth hormone release.
Negative Regulator:
Growth Hormone Release Inhibiting Hormone (somatostatin) from the periventricular nucleus inhibits adenyl cyclase, decreasing cAMP and blocking growth hormone release.
Both GHRH and somatostatin are essential for proper regulation.
A decrease in somatostatin leads to increased growth hormone release, but GHRH must also be present.
Effects of Growth Hormone
Insulin-like Growth Factors (IGFs)
Growth hormone stimulates the liver to secrete IGF-1 and IGF-2.
IGF-2 is crucial for fetal development, while IGF-1 mediates growth hormone's effects on:
Cartilage formation and bone growth
Protein synthesis
Muscle mass increase
Fat cell regulation
Pathological Conditions
Gigantism
Results from excessive growth hormone before puberty, causing elongation of long bones.
Individuals may grow up to 2 meters (8 feet) tall.
Acromegaly
Caused by growth hormone overproduction after puberty, leading to increased bone and cartilage growth but no height increase due to fused epiphyseal plates.
Symptoms include enlarged nose, ears, jaw, and internal organs.
Patients often experience a shortened lifespan.
Regulation Issues and Treatment
Increased Growth Hormone Causes
Hypothalamus: Low somatostatin or high GHRH
Pituitary: Pituitary tumors (e.g., adenomas)
Liver: Increased growth hormone receptors leading to excess IGF production
Treatment Approaches
Pituitary tumor removal for acromegaly.
Administration of IGF antagonists if IGF levels are elevated due to liver receptor issues.
Growth Hormone Deficiency
Symptoms in Children
Short stature, decreased muscle mass, increased adipose tissue
Low IGF levels associated with low growth hormone levels.
Diagnosis
Blood tests for growth hormone and IGF levels due to pulsatile nature of growth hormone release.
Testing can vary based on circadian rhythms.
Treatment Options
Synthetic growth hormone for low levels.
IGF administration if low IGF levels are the issue.
Ethical Considerations
Growth hormone therapy more common in boys than girls due to societal biases.
Debate on administering treatment to children within normal height ranges.
Risks of excessive growth hormone leading to conditions like gigantism and acromegaly.
Dwarfism Examples
Lehrone Syndrome
Autosomal recessive disorder with normal/high growth hormone but low IGF due to receptor issues at the liver.
Characterized by short stature, underdeveloped mandible, and truncal obesity.
Hypopituitary Dwarfism
Pituitary underdevelopment leads to low growth hormone and IGF levels.
Pygmy Dwarfism
Normal growth hormone levels but low IGF levels due to carrier protein issues. Proportional body build.
Nutrition Considerations
Rule out malnutrition when diagnosing dwarfism.
Combined Hormone Treatments
Growth hormone and thyroid hormone treatments are synergistic for growth enhancement, particularly in hypothyroid children.
Thyroid hormone increases growth hormone receptor sensitivity and promotes growth hormone efficacy.
Summation of Hormonal Interactions
Hormones can act permissively; the presence of one hormone enhances the effect of another.
Thyroid hormone acts to increase responses to epinephrine by increasing receptor numbers.
Conclusion
Overview of growth hormone regulation, effects of excess and deficiency, ethical considerations, and treatment options.
Next topics will shift focus to thyroid hormone regulation, synthesis, and mechanisms.